Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nivolumab in Combination With High Dose Radiotherapy at Varied Tumor Sites in Advanced Melanoma and no Prior Antitumoral Treatment

NCT02799901 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT02799901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02799901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nivolumab in Combination With High Dose Radiotherapy at Varied Tumor Sites in Advanced Melanoma and no Prior Antitumoral Treatment
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Phase 2
Overall status
Completed
Start date
March 3, 2017
Completion date
July 28, 2021
Enrollment
72 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma